NEW YORK (GenomeWeb News) – Pressure BioSciences today reported that its fiscal-year 2008 revenues rose 32 percent as sales for its pressure cycling technology products rose 64 percent for the year.

The South Easton, Mass.-based firm brought in revenues of $852,263 for the year ended Dec. 31, 2008, compared to revenues of $645,870 for 2007. The firm attributed the increase in revenues to a 105 percent increase in the number of installations of its PCT Sample Preparation Systems. During the year, it installed 41 of those systems compared to 20 the year before.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.